The whole month of April, and the week of 8-14 in particular are dedicated to Parkinson’s Disease Awareness.

More than 10 million people worldwide have Parkinson’s Disease. People suffering from this condition experience involuntary muscle movement, slowness of motion and shaking. The causes remain unknown, though they most likely are linked with certain genetic and environmental conditions.  Statistics have proven that people with Parkinson’s disease have a reduced life expectancy.

As of now, we do not have a cure for Parkinson’s disease. However, the symptoms are usually treated with special medications and an appropriate diet. Multiple studies have shown that such habits as exercising regularly, implementing antioxidants in the diet (precisely, Vitamin C and Vitamin E), and also consuming caffeine seem to reduce the risk of Parkinson’s Disease.

Dr. Jeffrey Apter, GCT President and Dr. Eugene Selivra, GCT CEO are both CNS professionals with more than 60 years of combined experience in the field. Global Clinical Trials has performed a great variety of CNS clinical studies during the 18 years of its existence. We are glad to use this opportunity to spread awareness about Parkinson’s Disease, and hope that more treatment options will be widely available for PD in the nearest future.